Category: news

Data featured in three oral and five poster presentations reinforce potential of novel antifungal for the treatment and prevention of…

ALAMEDA, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24BTX&src=ctag" target="_blank"gt;$BTXlt;/agt; lt;a href="https://twitter.com/hashtag/AMD?src=hash" target="_blank"gt;#AMDlt;/agt;–BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company developing new…

The world’s largest online marketplace rolls out first original service, empowering researchers with on demand insights into clinical trials to…

DUBLIN–(BUSINESS WIRE)–The “Hypotension – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Hypotension – Pipeline Review,…

DUBLIN–(BUSINESS WIRE)–The “Bacterial Vaginosis – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Bacterial Vaginosis –…

DUBLIN–(BUSINESS WIRE)–The “Cholera – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Cholera – Pipeline Review,…

DUBLIN–(BUSINESS WIRE)–The “Fatigue – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Fatigue – Pipeline Review,…

– Company’s Shares Will Trade Under New Ticker Symbol: ISEE – NEW YORK–(BUSINESS WIRE)–Ophthotech Corporation (Nasdaq:OPHT) today announced that as…

DUBLIN–(BUSINESS WIRE)–The “Post-Traumatic Stress Disorder (PTSD) – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Post-Traumatic…

DUBLIN–(BUSINESS WIRE)–The “Typhoid Fever – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Typhoid Fever –…